Medical artificial intelligence (AI) solution developer Lunit is showing strong performance on the 7th.
At 10:09 AM on this day, Lunit was trading at 108,600 KRW, up 10,200 KRW (10.37%) from the previous trading day.
Lunit announced that at the American Society of Clinical Oncology (ASCO 2023) held in Chicago, USA from the 2nd to the 6th (local time), it demonstrated the potential use of LunitScope as a biomarker proving the treatment efficacy for patients with locally advanced rectal cancer (LARC).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
